For the Quarter Ending December 2022
During the fourth quarter of 2022, Amphotericin B market dynamics fluctuated in the North American region. Prices were expected to increase starting in Q4 2022 and continuing through the second month of the quarter as a result of a high cost of manufacturing, numerous logistical issues, and rising inflation. Rising transportation costs and port congestion at the key ports also helped to keep the market position strong. A slowdown in API output, disorganization, and rising energy prices all had a positive effect on the market. Due to easing inflation and reducing end-user sector demand, prices started to decline later in December 2022. Values were accessed at USD 6265400/MT CFR Houston at the end of Q4 with an average quarterly inclination of 0.40%.
During the fourth quarter of 2022, the Amphotericin B market in the Asia-Pacific region showed a general downward trend. Amphotericin B costs have decreased quarterly due to reduced demand from the terminal pharmaceutical sector. An economy that was slowing down, plentiful supplies, and plenty of stocks supported this consistent pricing pattern. Later in December, prices significantly dropped as a result of a dip in domestic and international market inquiries brought on by the approaching holiday and festive season. The market was also impacted by sufficient supply and inventory levels. Towards the termination of Q4 2022, the values accessed at USD 6150500/MT with a quarterly declination of 0.15%.
In the European market, Amphotericin B prices followed an uptrend in the fourth Quarter of 2022 amidst soaring energy coast and squeezed manufacturing profit margins. Values were accessed at USD 6383940/MT at the end of Q4 2022, with an average quarterly incline of 0.61%. Inflation in the eurozone was recorded to reach a new high of 10.7% in October from 9.6% recorded in September. The price of natural gas for household consumers soared, influencing the market situation. Also, increased production costs kept the market sentiments robust. Later, from the second month of Q4, the prices were witnessed to follow the stable trajectory on the stable back demand from the end-user sector and enough inventories among the domestic merchants.
For the Quarter Ending September 2022
In the third quarter of 2022, Amphotericin B pricing patterns have seen a declining trend in the North American market. The hindered global trade operations have significantly impacted the price chain of Amphotericin B in the regional market. Due to decreased demand from the end-user industry and growing inflation, Amphotericin B's diminishing market values among dealers have been further supported. The cost was USD 6192500/MT at the end of Q3 2022, with a 2.42% decline in the average quarterly cost. Amphotericin B prices decreased in the third quarter across the local market due to lower production and input costs.
The Asia-Pacific region's Amphotericin B market declined during the third quarter of 2022. The quarter-long decline in Amphotericin B prices results from weak demand from the terminal pharmaceutical industry. This downward price trend was backed by a slowing economy, enough supplies, and ample stocks. Prices dramatically climbed towards the end of the second half of Q3 due to an increase in domestic and foreign market inquiries. A limited supply also impacted the market in the previous month due to the last production halts, trade activities after lousy weather, and zero covid policies. Weak demand fundamentals and consistent supply drove the Amphotericin B market's negative trajectory. Towards the termination of Q3 2022, the values accessed at USD 6180500/MT with a quarterly declination of 1.32%.
Due to weak downstream pharmaceutical demand dynamics, the market for Amphotericin B shrank in the third quarter of 2022. Values were accessible at USD 6268960/MT at the end of Q3 2022, with an average quarterly decline of 3.70%. The declining offtakes from the regional market, which resulted in subdued trading dynamic, were another factor that caused the values to plunge. The end-user supplier and dealers haggled over their already-stockpiled commodities to retain their profit margins. Operating costs, raw material prices, and purchasing activity all decreased slightly. All of these factors contributed to the declining market dynamics and the downward movement of Amphotericin B's price.
For the Quarter Ending June 2022
The Amphotericin market has stable market sentiments in the US market amid firm demand fundamentals. The unmoving demand from the downstream pharmaceuticals sector has propelled the market of Amphotericin B in the regional market to be at ease. The supply chain bottlenecks brought on by the Russia-Ukraine war have severely impacted global trade activities and exerted enough cost pressure on the price value chain of Amphotericin B. Furthermore, the curtailed availability of the product created by prolonged port congestion In China and supply chain disruptions has influenced the pricing dynamics of Amphotericin B in the United States. In addition, the higher freight charged has also contributed to the escalated offers for Amphotericin B in the USA. Towards the termination of Q2 2022, the values accessed at USD 6904640/MT with a quarterly inclination of 1.94%.
During the second quarter of 2022, the price trends of Amphotericin B have demonstrated mixed market sentiments. In the Asia-Pacific region, the market prices of Amphotericin B have witnessed a gradual fall till mid-Q2 due to ample availability of the product in the domestic region and then escalated in the second half. The copious supplies of Amphotericin B have provoked the manufacturers to revise their quotations. Furthermore, towards the end of the second quarter, Amphotericin B's spot offers improved amid the staggering inquiries from domestic and international markets. The robust demand from the downstream pharmaceutical sector has driven the market growth of Amphotericin B in the regional market. Towards the termination of Q2 2022, the values accessed at USD 6433700/MT with a quarterly inclination of 0.77%.
In the European region, the price discussions of Amphotericin B substantially dropdown at the start of the second quarter. With enough inventories and limited inquiries, the market sentiments were at ease. With onset of second half of Q2 2022, the costs of energy materials have significantly surged in the domestic region of Germany, inciting the manufacturing costs to demonstrate an uptrend, affecting the market sentiments for Amphotericin B. Furthermore, towards the mid-second quarter, economic growth slowed in the entire European region amid the fallout from the war between Russia and Ukraine. The undermined consumer purchasing power and exacerbated global supply chain issues have caused the market value of Amphotericin B to remain sturdy. Towards the termination of Q2 2022, the values accessed at USD 7050860/MT with a quarterly declination of 0.02%. However, the increased inquiries from the terminal end have improved the spot offers for Amphotericin B at the end of the second quarter.